carbamazepine has been researched along with Charcot-Marie-Tooth Disease in 6 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Charcot-Marie-Tooth Disease: A hereditary motor and sensory neuropathy transmitted most often as an autosomal dominant trait and characterized by progressive distal wasting and loss of reflexes in the muscles of the legs (and occasionally involving the arms). Onset is usually in the second to fourth decade of life. This condition has been divided into two subtypes, hereditary motor and sensory neuropathy (HMSN) types I and II. HMSN I is associated with abnormal nerve conduction velocities and nerve hypertrophy, features not seen in HMSN II. (Adams et al., Principles of Neurology, 6th ed, p1343)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Notably, we demonstrated the positive effects of carbamazepine in treating muscle stiffness and cramps of ARAN-NM." | 5.22 | A novel mutation in HINT1 gene causes autosomal recessive axonal neuropathy with neuromyotonia, effective treatment with carbamazepine and review of the literature. ( Lin, P; Lv, X; Wang, G; Xu, L; Yan, C; Zhang, D, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, L | 1 |
| Wang, G | 1 |
| Lv, X | 1 |
| Zhang, D | 1 |
| Yan, C | 1 |
| Lin, P | 1 |
| Tekkok, IH | 1 |
| Sumer, M | 1 |
| Piantino, JA | 1 |
| Torres, A | 1 |
| Tacconi, L | 1 |
| Miles, JB | 1 |
| Lance, JW | 1 |
| Durke, D | 1 |
| Pollard, J | 1 |
| Serratrice, G | 1 |
| Pouget, J | 1 |
| Pellissier, JF | 1 |
| Cros, D | 1 |
2 reviews available for carbamazepine and Charcot-Marie-Tooth Disease
| Article | Year |
|---|---|
A novel mutation in HINT1 gene causes autosomal recessive axonal neuropathy with neuromyotonia, effective treatment with carbamazepine and review of the literature.
Topics: Adolescent; Carbamazepine; Charcot-Marie-Tooth Disease; Histidine; Humans; Isaacs Syndrome; Muscle C | 2022 |
[Carbamazepine-sensitive neuromyotonia and Charcot-Marie-Tooth disease of the neuronal type].
Topics: Adolescent; Carbamazepine; Charcot-Marie-Tooth Disease; Humans; Male; Muscular Atrophy, Spinal; Neur | 1989 |
4 other studies available for carbamazepine and Charcot-Marie-Tooth Disease
| Article | Year |
|---|---|
Bilateral trigeminal neuralgia and charcot-marie-tooth disease: diagnosis and successful microsurgical treatment of bilateral neurovascular compression.
Topics: Adult; Analgesics, Non-Narcotic; Atrophy; Carbamazepine; Cerebral Revascularization; Charcot-Marie-T | 2008 |
Myoclonic seizures in a patient with Charcot-Marie-tooth disease.
Topics: Anticonvulsants; Carbamazepine; Charcot-Marie-Tooth Disease; Child; Developmental Disabilities; Drug | 2007 |
Bilateral trigeminal neuralgia: a therapeutic dilemma.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Charcot-Marie-Tooth Disease; Cryotherapy; Female; Human | 2000 |
Neuromyotonia in the spinal form of Charcot-Marie-Tooth disease.
Topics: Adult; Aged; Carbamazepine; Charcot-Marie-Tooth Disease; Electromyography; Fasciculation; Female; Hu | 1979 |